Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateLouisianaEnacted
SB 401: PHARMACEUTICALS: Provides for a Prescription Drug Affordability Board. (8/1/26)
Kirk Talbot
SB 401 status: Enacted — Signed by the Governor. Becomes Act No. 915 (updated Jun 12, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
50OUT OF 100
Score:50/100 civic fit — mixed
Risk:Moderate Risk
Impact:Moderate Impact 60/100
Constitutionality50%
Bipartisan50%
Public opinion50%
Bill summary
What changes
The bill establishes a state-level Prescription Drug Affordability Board tasked with evaluating and addressing the high costs of certain pharmaceutical drugs.
Who is affected
Pharmaceutical companies, healthcare providers, insurance payers, and state residents requiring prescription medications.
Requirements and enforcement
The board is required to be established and commence operations by August 1, 2026.
Costs and funding
Not stated in the available source; fiscal impact on state budget or administrative funding is unknown.
When it takes effect
The board's work begins August 1, 2026.
Potential benefits
Potential for reduced consumer costs for prescription drugs and greater state oversight of pharmaceutical pricing.
Risks and tradeoffs
Potential for drug supply disruption, legal challenges regarding market intervention, and administrative overhead.
What is still unknown
Exact membership of the board, specific criteria for drug cost reviews, and the extent of the board's enforcement or price-setting powers.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
50%
Benefits
- Potential reduction in state healthcare costs
- Framework for oversight of drug pricing
- Increased focus on consumer cost protection
Risks
- Increased administrative and regulatory burden
- Potential for pharmaceutical industry legal challenges
- Risk of market distortions or price shifting
Society
Mixed / Neutral
50%
Benefits
- Improved affordability for essential medications
- Reduced financial burden on lower-income families
- Potential for improved medication adherence
Risks
- Risk of creating exclusionary drug lists
- Potential for reduced access to new, expensive therapies
- Administrative delays in drug affordability reviews
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Mixed / Neutral
50%
Benefits
- Creation of a formal state oversight entity
- Public reporting requirements for board actions
- Centralization of prescription drug policy
Risks
- Potential for industry lobbying on the board
- Lack of detailed operational transparency requirements
- Risk of political influence in board appointments
Public Health & Safety
Mixed / Neutral
50%
Benefits
- Increased access to life-saving medications
- Prioritization of affordability for essential drugs
- Data-driven focus on health outcomes
Risks
- Risk of restricting access to new medical innovations
- Bureaucratic interference in clinical decision-making
- Possible delays in access due to review processes
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
LegiScan returned a PDF-only document. PDF extraction is not enabled in this build, so the pipeline used a safer fallback.
Analysis scope
Source provided is a summary and lacks full bill text details.
04
Where it stands
Official recordSigned by the Governor. Becomes Act No. 915.
- IntroducedComplete
- CommitteeComplete
- Chamber votesComplete
- Final agreementComplete
- GovernorComplete
- EnactedComplete
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.